Researchers from the University of Oregon (OR, USA) suggest that noninvasive EEG readings could present as easily detectable biomarkers to help diagnose and improve treatment for Parkinson’s and other motor disorders.
Browsing: Movement Disorders
Whilst at the AD/PD™ conference, we had the pleasure of speaking with Patrik Brundin about his talk on novel therapeutic targets for Parkinson’s disease.
A recently published study has provided evidence that could potentially aid reports into dogs detecting an epileptic seizure odor.
An abstract to be presented by the American Academy of Neurology (CA, USA) reports patients suffering from hand tremors may find relief with a novel, non-invasive nerve stimulation treatment.
Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson’s disease
This research article from Neurodegenerative Disease Management investigates how age and disease duration affects Parkinson’s treatment outcome with levodopa-carbidopa intestinal gel.
NCTalks on neuromodulation in children: an interview with Jean-Pierre Lin, President of the British Paediatric Neurology Association
Dr Lin tells Lauren Pulling (Editor, NC) about his work as a pediatric neurologist, and recent advances in deep brain stimulation for infants.
#NCintroduces… Going through the motions: how modern techniques have changed the face of Parkinson’s research
Tom Naughton introduces the circuitry underlying Parkinson’s disease, and how our understanding and new techniques have advanced hand-in-hand to bring us to where we are now.
Dr Vitek discusses the Neuromodulation Research Center, progression in the field, and the biggest challenges associated with developing new neuromodulation therapies for conditions such as Parkinson’s disease.
Angelman syndrome and Dup15q syndrome: two rare diseases working together to solve each other’s puzzles – a conversation with Jill Silverman and Nathalie Buscher
In this interview, Drs Silverman and Buscher discuss their work, and how these two rare diseases are shedding light not only on each other, but also a wealth of other neurological disorders.
Is bone marrow transplantation a viable treatment option for relapsing–remitting MS? Jeffrey Cohen discusses pros and cons of the technique.